Krameria lappacea
Krameria lappacea · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Krameria lappacea is a botanical species known for possessing significant bioactive properties derived primarily from its root. The plant contains key chemical compounds such as tannins and 2-(2,4-dihydroxyphenyl)-5-(e)-propenylbenzofuran, which contribute to its complex biological profile. Research into its various preparations, including KLRE and specialized root extracts, has highlighted its diverse activities as an absorbent and an allelochemic agent. Notably, these extracts demonstrate potent antibacterial potential, showing promise in addressing challenging conditions like Methicillin-Resistant Staphylococcus aureus (MRSA). Furthermore, the plant's ability to act as an ACE-inhibitor suggests valuable applications in broader pharmacological studies.
- Synonyms
- Krameria Triandra · Krameria Pentapetala · 3 more
- Common names
- Not available
- Family
- Krameriaceae
- Distribution
- Africa
- Plant Parts
- Root
Classification
Common Names
Krameria lappacea is a versatile botanical species known by a diverse array of regional monikers. It is frequently referred to as Peruvian Rhatany or simply Ratanhia in many botanical circles. Depending on the local culture, the plant is also commonly called Chipichape or Pumacuchu. Furthermore, it holds the distinctive local name Mapato in certain areas. These various names highlight the plant's widespread recognition and cultural significance across different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Krameria lappacea is a botanical species that has historically been associated with several different taxonomic designations. Scientific literature identifies various synonyms for this plant, including the names Krameria canescens and Krameria illuca. Furthermore, it has been categorized under the synonym Krameria pentapetala in certain contexts. The plant is also linked to Krameria triandra, which encompasses a variety of classifications. Finally, this group includes the specific variation known as Krameria triandra var. humboldtiana.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Krameria lappacea is a distinctive biological specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Zygophyllales, showcasing its specific evolutionary lineage. This species is a member of the genus Krameria, which highlights its unique botanical characteristics. Finally, its taxonomic placement is completed by its membership in the family Krameriaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Zygophyllales |
| Family | Krameriaceae |
| Genus | Krameria |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Krameria lappacea is a resilient species with a broad geographical footprint across the South American continent. Its natural range extends through the southern reaches of the land, specifically covering parts of Argentina's northwest and various regions of Chile, from the north to the central territories. Moving westward, the plant also establishes itself within the diverse landscapes of Western South America. This distribution includes significant populations found throughout Bolivia and Ecuador. Such a wide-reaching presence highlights the plant's ability to adapt to various South American environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Krameria lappacea is a self-supporting shrub that maintains a compact presence in its natural habitat. This plant typically reaches a maximum height of only 0.8 meters. Its low-growing growth form makes it a distinctive feature of its local ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Krameria lappacea has demonstrated significant therapeutic potential through its diverse biological activities. Research indicates that this medicinal plant possesses potent antibacterial properties, specifically showing effectiveness against methicillin-resistant Staphylococcus aureus (MRSA) strains. Beyond its ability to inhibit bacterial growth, the plant also exhibits notable antifungal activity against various human pathogenic fungi. These combined effects highlight its broader antimicrobial action, which is essential for addressing infectious diseases. Such findings underscore the importance of the plant's chemical compounds, including neolignans and flavonoids, in combating a wide range of pathogens.
Compounds
Krameria lappacea is closely related to other tannin-rich species mentioned in recent botanical studies. While the provided research focuses on the high tannin concentrations found in Syzygium jambos, it also evaluates several comparative plant extracts. Among these comparisons are species like Krameria triandra, which possesses a significant tannin content of 44%. These tannins play a crucial role in determining the antimicrobial efficacy of various plant-based extracts. Ultimately, understanding these chemical relationships helps researchers identify which plants may offer the strongest defense against micro-organisms.
Conditions
Krameria lappacea demonstrates significant therapeutic potential by exhibiting antitumor effects that can help treat breast cancer (BC). This medicinal plant also shows high sensitivity in treating various Gram-positive strains of clinical interest. Specifically, its root extract has proven effective in treating Methicillin-Resistant Staphylococcus aureus (MRSA). The plant's bioactive compounds, such as flavonoids and proanthocyanidins, are also capable of treating adhesion by inhibiting the ability of MRSA to attach to human lung carcinoma cells. Together, these properties highlight the diverse antimicrobial and anticancer capabilities of the species.
Preparations
Krameria lappacea is prepared as extracts, such as ethanol extracts, which have demonstrated significant antiproliferative activity against Hep3B human hepatocellular carcinoma cells. This medicinal plant is also prepared as a root extract to investigate its potential biological properties. Specifically, the plant is prepared as KLRE, a designation used to identify the specialized root extract during chemical and antibacterial analyses. The KLRE has been shown to efficiently inhibit the growth, biofilm formation, adhesion, and invasion of methicillin-resistant Staphylococcus aureus strains. Through these various preparations, the plant's bioactive compounds, including flavonoids and proanthocyanidins, are utilized for therapeutic study.
Parts used
Krameria lappacea is a medicinal plant native to South America that offers significant therapeutic potential through its root components. Research indicates that lignan derivatives isolated from the roots can enhance endothelial nitric oxide synthase activity, which supports vital vaso-protective and immunomodulatory functions. Furthermore, root extracts from this species demonstrate potent antibacterial properties, effectively inhibiting the growth and biofilm formation of MRSA strains. These biological activities are largely attributed to the presence of various flavonoids and proanthocyanidins found within the plant tissue. Consequently, the chemical composition of the Krameria lappacea root makes it a valuable subject for developing new antimicrobial and cardiovascular treatments.